Today: 7 February 2026
Subscribe

SiTime stock slumps 9% after topping Wall Street targets, bucking chip rally

SiTime stock slumps 9% after topping Wall Street targets, bucking chip rally

SiTime shares fell nearly 9% to $336.50 Monday afternoon, erasing earlier gains and much of their start-of-year advance. The drop came after the stock surpassed the average analyst target of $355, drawing valuation scrutiny. The move contrasted with a 1.7% gain in the PHLX Semiconductor Index as chip stocks broadly rallied. Investors are watching for SiTime’s next earnings update.
5 January 2026
····
Structure Therapeutics stock slides nearly 8% as Novo’s Wegovy pill debut jolts oral obesity-drug bets

Structure Therapeutics stock slides nearly 8% as Novo’s Wegovy pill debut jolts oral obesity-drug bets

Structure Therapeutics shares fell 7.7% to $62.86 after Novo Nordisk began U.S. sales of its Wegovy pill at $149 a month for self-paying patients. Structure’s stock had reached $72.02 earlier in the session before retreating. Investors await updates on its Phase 3 plans and next earnings report, expected Feb. 26.
5 January 2026
·····
XRP price today: Ripple-linked token jumps above $2.20 as crypto stocks rise, CoinShares flags inflow surge

XRP price today: Ripple-linked token jumps above $2.20 as crypto stocks rise, CoinShares flags inflow surge

XRP climbed about 7% to $2.23 Monday, trading between $2.07 and $2.23 in the past 24 hours, with $4.1 billion in volume and a market value near $135 billion, CoinMarketCap said. CoinShares reported $3.7 billion in 2025 inflows to XRP-linked investment products, a 500% jump from the previous year. Bitcoin rose 3% near $94,000, ether gained 2% to $3,200. Coinbase shares advanced 7.4% in regular U.S. trading.
5 January 2026
··
Astera Labs stock drops 8% after insider sale plan disclosed — what traders watch next

Astera Labs stock drops 8% after insider sale plan disclosed — what traders watch next

Astera Labs shares dropped 8.4% to $164.50 Monday after a regulatory filing showed general counsel Philip Mazzara plans to sell 30,000 shares worth about $5 million. The stock reversed from a session high near $185, trading over 5 million shares by early afternoon. Semiconductor ETFs rose, but Astera lagged. Investors are watching for further insider filings and signals from hyperscale customers.
5 January 2026
·
Bitcoin price jumps near $94,000 as Coinbase stock surges on Goldman upgrade, Strategy buys more BTC

Bitcoin price jumps near $94,000 as Coinbase stock surges on Goldman upgrade, Strategy buys more BTC

Bitcoin climbed 3.3% to $94,161 in New York afternoon trading Monday, with Coinbase jumping 7.6% after a Goldman Sachs upgrade. Strategy disclosed buying 1,283 bitcoin for $116 million in an SEC filing. Crypto stocks and tokens tracked the move higher as traders watched fallout from the U.S. capture of Venezuela’s president and awaited U.S. jobs data due Friday.
5 January 2026
······
Silver price stock SLV climbs nearly 6% as Venezuela strikes lift safe-haven demand

Silver price stock SLV climbs nearly 6% as Venezuela strikes lift safe-haven demand

Shares of iShares Silver Trust (SLV) jumped 5.7% to $69.49 and spot silver rose 6% to $76.99 an ounce Monday after U.S. strikes in Venezuela spurred safe-haven demand. Traders are watching upcoming U.S. jobs and inflation data for signals on interest rates. Silver hit an all-time high of $83.62 recently. The U.S. employment report is due Friday.
5 January 2026
···
Gold price jumps on Venezuela strikes, lifting GLD and gold miners in New York trade

Gold price jumps on Venezuela strikes, lifting GLD and gold miners in New York trade

Spot gold jumped 2.7% to $4,447.05 an ounce after U.S. strikes in Venezuela triggered safe-haven demand. The SPDR Gold Shares ETF rose 2.6% and the VanEck Gold Miners ETF gained 4.6% in New York trading. Miners Newmont and Agnico Eagle advanced 2.4% and 4.5%, respectively. Investors are watching Friday’s U.S. jobs report for signals on Federal Reserve policy.
5 January 2026
··
Arrowhead Pharmaceuticals stock slides despite Health Canada approval of Redemplo — what investors watch next

Arrowhead Pharmaceuticals stock slides despite Health Canada approval of Redemplo — what investors watch next

Arrowhead Pharmaceuticals shares fell 6.9% to $63.11 Monday after Health Canada approved Redemplo, its triglyceride-lowering drug for familial chylomicronemia syndrome. The stock dropped despite the clearance, tracking weakness across biotech stocks. Investors now await Arrowhead’s obesity data webinar on Jan. 6 and its J.P. Morgan conference presentation Jan. 12.
5 January 2026
···
Chevron stock jumps on Trump Venezuela oil move; traders eye sanctions and Jan. 30 earnings

Chevron stock jumps on Trump Venezuela oil move; traders eye sanctions and Jan. 30 earnings

Chevron shares jumped 5.7% to $164.78 after U.S. forces captured Venezuelan President Nicolás Maduro, fueling bets on renewed access to Venezuela’s oil. Chevron, the only U.S. major still operating there under a waiver, exported up to 150,000 barrels per day to the U.S. Gulf Coast late last year. ConocoPhillips and Exxon Mobil also gained. Brent crude rose 1.58% to $61.71 a barrel.
5 January 2026
······
Ondas Holdings stock rises on Jan. 16 investor day plan, SEC resale filing sharpens focus on 2026 outlook

Ondas Holdings stock rises on Jan. 16 investor day plan, SEC resale filing sharpens focus on 2026 outlook

Ondas Holdings shares rose 6.5% to $11.74 Monday after the company set a Jan. 16 investor day focused on its autonomous systems unit and 2026 outlook. A new SEC filing registered 2.39 million shares for resale by holders tied to a prior subsidiary securities exchange. The stock traded between $11.01 and $11.81, with about 71 million shares changing hands by early afternoon.
5 January 2026
1 … 558 559 560 561 562 … 1,636

Stock Market Today

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
GE Vernova stock closes up nearly 6% — what to watch before Monday’s trade

GE Vernova stock closes up nearly 6% — what to watch before Monday’s trade

7 February 2026
GE Vernova shares jumped 5.6% to $779.35 Friday as Wall Street rallied and the company reported 1.1 GW of U.S. wind repower orders for 2025. The company also closed its $5.3 billion purchase of the remaining Prolec GE stake and completed a $2.6 billion senior notes offering. Investors await next week’s U.S. jobs and inflation data.
Go toTop